Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Regulus Therapeutics Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −3 vs. Q3 2021
- Shares held
- 30.2M
- +7.21M (+31.4%) vs. Q3 2021
- Total value
- $9.54M
- −$6.32M (−39.9%) vs. Q3 2021
- New holders
- 7
- 8 more added
- Sold out
- 10
- 8 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $760 |
| Q1 2025 | 75 | $107.0M |
| Q4 2024 | 69 | $84.5M |
| Q3 2024 | 70 | $89.1M |
| Q2 2024 | 63 | $109.5M |
| Q1 2024 | 45 | $147.3M |
| Q4 2023 | 26 | $14.2M |
| Q3 2023 | 25 | $15.0M |
| Q2 2023 | 26 | $15.0M |
| Q1 2023 | 27 | $6.82M |
| Q4 2022 | 28 | $11.1M |
| Q3 2022 | 25 | $13.8M |
| Q2 2022 | 28 | $12.6M |
| Q1 2022 | 37 | $18.1M |
| Q4 2021 | 38 | $9.54M |
| Q3 2021 | 42 | $15.9M |
| Q2 2021 | 45 | $18.7M |
| Q1 2021 | 44 | $42.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Regulus Therapeutics Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 1,049 | $0 | 0.00% | −17,274−94.3% | Reduced |
| FMR LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 6,000 | $2.00K | 0.00% | −558,462−98.9% | Reduced |
| Wells Fargo & Company | 6,848 | $2.00K | 0.00% | −237−3.3% | Reduced |
| Royal Bank of Canada | 7,063 | $2.00K | 0.00% | 00.0% | Unchanged |
| Community Bank, N.A. | 6,900 | $2.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 6,927 | $2.00K | 0.00% | +4,607+198.6% | Added |
| Endurance Wealth Management, Inc. | 6,750 | $2.00K | 0.00% | +6,750 | New |
| Tower Research Capital LLC (TRC) | 6,841 | $2.00K | 0.00% | +6,841 | New |
| Blair William & Co | 10,700 | $3.00K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 14,200 | $4.00K | 0.00% | 00.0% | Unchanged |
| Dowling & Yahnke LLC | 12,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| All Terrain Financial Advisors, LLC | 15,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| McGuire Investment Group, LLC | 15,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 22,300 | $7.00K | 0.00% | +22,300 | New |
| UBS Group AG | 23,953 | $8.00K | 0.00% | +4,079+20.5% | Added |
| Jane Street Group, LLC | 24,426 | $8.00K | 0.00% | +24,426 | New |
| GYL Financial Synergies, LLC | 41,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Lido Advisors, LLC | 54,500 | $17.0K | 0.00% | −3,000−5.2% | Reduced |
| Two Sigma Investments, LP | 55,306 | $17.0K | 0.00% | +55,306 | New |
| Grimes & Company, Inc. | 61,076 | $19.0K | 0.00% | −10,595−14.8% | Reduced |
| WealthTrust Axiom LLC | 68,000 | $21.0K | 0.01% | +55,000+423.1% | Added |
| Group One Trading, L.P. | 88,177 | $28.0K | 0.00% | −900−1.0% | Reduced |
| Northern Trust Corp | 117,654 | $37.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 119,000 | $37.0K | 0.00% | +8,000+7.2% | Added |
| Boothbay Fund Management, LLC | 124,056 | $39.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 151,300 | $48.0K | 0.00% | +139,400+1,171.4% | Added |
| State Street Corp | 176,494 | $56.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 184,600 | $58.0K | 0.00% | +146,500+384.5% | Added |
| Geode Capital Management, LLC | 589,196 | $185.0K | 0.00% | −81,551−12.2% | Reduced |
| Ikarian Capital, LLC | 1,228,416 | $388.0K | 0.11% | 00.0% | Unchanged |
| Sarissa Capital Management LP | 1,851,851 | $583.0K | 0.05% | 00.0% | Unchanged |
| Victory Capital Management Inc | 2,233,544 | $704.0K | 0.00% | +6,332+0.3% | Added |
| Asymmetry Capital Management, L.P. | 2,731,044 | $860.0K | 0.46% | +1,329,553+94.9% | Added |
| Vanguard Group Inc | 3,030,213 | $955.0K | 0.00% | −74,832−2.4% | Reduced |
| Empery Asset Management, LP | 5,074,251 | $1.60M | 3.34% | +5,074,251 | New |
| DAFNA Capital Management LLC | 5,555,555 | $1.75M | 0.44% | +5,555,555 | New |
| NEA Management Company, LLC | 6,451,056 | $2.06M | 0.04% | 00.0% | Unchanged |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −3,547,208−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −393,307−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −246,191−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −164,155−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −64,708−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −35,357−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −10,610−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Sonora Investment Management, LLC | – | – | – | – | Not filed |